Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.
about
FSGS: Diagnosis and Diagnostic Work-UpSecondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to GlomerulosclerosisDevelopment of focal segmental glomerulosclerosis after anabolic steroid abuseDiabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Heart-type fatty acid binding protein is associated with proteinuria in obesity.Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?Towards a definition of glomerulomegaly: clinical-pathological and methodological considerationsEndothelin and the podocyteShort-Term High Fat Intake Does Not Significantly Alter Markers of Renal Function or Inflammation in Young Male Sprague-Dawley Rats.Inflammation and oxidative stress in obesity-related glomerulopathyThe link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.Lifestyle modification and progressive renal failure.Obesity and diabetic kidney disease.Emerging global epidemic of obesity: the renal perspective.Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease.Adverse renal consequences of obesity.Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort StudyEffects of high-fat diet and losartan on renal cortical blood flow using contrast ultrasound imaging.Consequences of morbid obesity on the kidney. Where are we going?Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts.Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study.Scope and mechanisms of obesity-related renal disease.Mechanisms of obesity-induced hypertension.The conflicting effects of maternal nutrient restriction and early-life obesity on renal health.Bariatric surgery and renal function.Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.Kidney aging--inevitable or preventable?Can vitamin D slow down the progression of chronic kidney disease?Anaplastic lymphoma kinase: activating mechanisms and signaling pathways.The effect of weight loss in obesity and chronic kidney disease.GFR estimation in the morbidly obese pre- and postbariatric surgery: one size does not fit all.The biological consequence of obesity on the kidney.Obesity-related glomerulopathy and the nephron complement.The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis.Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.Applicability of the glomerular size distribution coefficient in assessing human glomerular volume: the Weibel and Gomez method revisited.
P2860
Q26744558-8DCD8C67-219A-4507-9F9B-67C8A23B4DFEQ26752830-E29EA3F5-653E-4B73-A4DB-1D4A8F316807Q33562274-B8BDB470-AB4F-455C-8CF0-28C6AC93C9EEQ33583012-93DB9DD9-0DF0-4986-8BEC-F65509747FFBQ34429806-C1B2AE6A-1624-4DD9-8944-B10413F87A91Q34556394-35ADFFF0-90F1-4A3C-98A9-D64D1547B460Q35065516-6FB58C50-CF02-4030-A37A-DF5CC9FFDA27Q35188523-9033D3C7-24FF-4D00-B12A-D42543F927E4Q35452282-4BA4F212-B8E9-4B41-8021-0469042A7AADQ35817372-0F068FF9-166C-45B8-9A51-3C8724D114CEQ35904102-89BA6841-FD0B-46CF-8D5C-DB3DB0670455Q35916243-CAAB2CAF-376C-481B-B8CE-130C1C676531Q36234287-73E4DDB1-851A-47F5-84F8-41E97023EFE9Q36515043-C9116F01-5FCA-415D-8F7E-437D65652900Q36554341-69D5C811-F1B9-42C0-A1E6-236F4C6FBBD4Q36734070-CCDABCD1-F0B1-4200-93B0-137E0A75CE8AQ37051981-BA575D20-7E6D-4F1F-A217-2B6E40F6A1E7Q37072213-251A7223-DF97-4E35-92A5-9C4C1E7BC6B3Q37114337-F378266E-5E8C-47A8-883D-95BCD0FEC34CQ37342006-F39C5BF4-7BD0-46AC-AC3F-B40E602089A0Q37511029-3606A8FF-B95B-4378-AB15-6F4B7F18CA7DQ37640916-4101A7AF-320A-4512-A4EB-AA967B46BD4AQ37671788-FC1151F5-BF02-4FCA-98AA-5539A3E4E9EEQ37687825-7480D0F4-8BCC-4855-B0EC-8EEC31371BCDQ37742440-B00F690D-F921-42F5-8FE9-3C9248F815C3Q37828185-3AEBFBD1-0404-4B88-8439-6418B1C05D43Q37843766-0FD18CE7-8652-4BEE-8D1B-7A90962BC77BQ37886981-2E0C1E7C-CF38-4859-8EFF-7FD301561C7BQ37913979-B319CD3C-7F1E-4A4D-BCC0-D58319E970EFQ37967396-DD7993E6-3A02-48E8-AEBF-E55E9C0E5143Q37971668-05CF1B86-3F5F-4156-8A70-C94A2A69233EQ37976970-D00868D4-5048-490C-8E75-07239E569F96Q37990437-BA1795EA-4276-42E3-A263-40A2C5E8717DQ38112518-D5802339-F4BC-4936-B850-A0C9FDF74AFBQ38122630-1DFEB356-6275-4526-8B4A-E3EA79B4524BQ38144642-8EA6882E-273D-486B-95B9-038132E61373Q38282228-0AA0B344-FB09-48A8-960A-6C45C02D55FAQ40188954-6FCA8E89-7FD4-4007-859C-5D4D05D7B710Q40192525-572568FF-4413-4697-93AA-C0AFA5F190CAQ40225100-F12EE9A6-7987-4E41-B8DC-33813AC28512
P2860
Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clinical features and long-ter ...... segmental glomerulosclerosis.
@en
Clinical features and long-ter ...... segmental glomerulosclerosis.
@nl
type
label
Clinical features and long-ter ...... segmental glomerulosclerosis.
@en
Clinical features and long-ter ...... segmental glomerulosclerosis.
@nl
prefLabel
Clinical features and long-ter ...... segmental glomerulosclerosis.
@en
Clinical features and long-ter ...... segmental glomerulosclerosis.
@nl
P2093
P2860
P356
P1476
Clinical features and long-ter ...... segmental glomerulosclerosis.
@en
P2093
P2860
P304
P356
10.1093/NDT/16.9.1790
P407
P577
2001-09-01T00:00:00Z